These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9638394)

  • 21. Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
    Eversole A; Hancock W; Johns T; Lopez LM; Conti CR
    Clin Cardiol; 2001 Jul; 24(7):521-5. PubMed ID: 11444644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
    Van Gelder IC; Tuinenburg AE; Schoonderwoerd BS; Tieleman RG; Crijns HJ
    Am J Cardiol; 1999 Nov; 84(9A):147R-151R. PubMed ID: 10568674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ibutilide in rapid conversion of atrial flutter in octogenarians.
    Antonicelli R; Testarmata P; Recanatini A
    Drugs Aging; 2002; 19(10):787-91. PubMed ID: 12390055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
    Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
    Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion.
    Domanovits H; Schillinger M; Thoennissen J; Nikfardjam M; Janata K; Brunner M; Laggner AN
    Resuscitation; 2000 Aug; 45(3):181-7. PubMed ID: 10959017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
    Thind M; Crijns HJ; Naccarelli GV; Reiffel JA; Corp Dit Genti V; Wieloch M; Koren A; Kowey PR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1022-1030. PubMed ID: 32083368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
    Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter.
    Rogers KC; Wolfe DA
    J Emerg Med; 2001 Jan; 20(1):67-71. PubMed ID: 11165840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute conversion of atrial fibrillation and flutter: direct current cardioversion versus intravenously administered pure class III agents.
    Singh BN
    J Am Coll Cardiol; 1997 Feb; 29(2):391-3. PubMed ID: 9014994
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction: acute treatment of atrial fibrillation and flutter--ibutilide in perspective.
    Waldo AL; Pratt CM
    Am J Cardiol; 1996 Oct; 78(8A):1-2. PubMed ID: 8903268
    [No Abstract]   [Full Text] [Related]  

  • 34. The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
    Hoyer AW; Balaji S
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1003-8. PubMed ID: 17669084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter.
    Malviya A; Kapoor M; Sivam RKN; Khan SA; Pandey R; Kumar U; Ete T; Mishra A
    Indian Heart J; 2020; 72(4):283-288. PubMed ID: 32861384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm.
    Dilaveris P; Synetos A; Giannopoulos G; Gialafos E; Stefanadis C
    Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):382-6. PubMed ID: 16029392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Termination of acute wide QRS complex atrial fibrillation with ibutilide.
    Sobel RM; Dhruva NN
    Am J Emerg Med; 2000 Jul; 18(4):462-4. PubMed ID: 10919540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department.
    Stiell IG; Macle L;
    Can J Cardiol; 2011; 27(1):38-46. PubMed ID: 21329861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of ibutilide for conversion of atrial fibrillation/flutter].
    Yu Z; Xiang M; Ma C; Zhang S; Yang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 42(2):212-6. PubMed ID: 23585009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.
    Gowda RM; Punukollu G; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Am J Ther; 2003; 10(4):259-63. PubMed ID: 12845389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.